Skip to content
Search

Latest Stories

New report reveals small rise in NHS dental workforce in England

New report reveals small rise in NHS dental workforce in England

More than 30 million courses of dental treatment were delivered in 2023/24 in England  

A new report published by the NHS Business Services Authority (NHSBSA) reveals that 24,300 dentists performed NHS dental activity in England in 2023/24, marking a 0.4 per cent rise from the previous year’s 24,227.

However, this figure represents a 1.5 per cent decrease from 24,700 dentists with NHS activity in 2019/20.


The report covers NHS dental activity and the NHS dental workforce in England from 2019/20 to 2023/24.

It is the first release from NHSBSA following the transition from NHS England, which previously issued the report.

There were 34 million courses of dental treatment in England for 2023/24, a 4.3 per cent increase from 2022/23. The total units of dental activity (UDAs) rose by 3.4 per cent to 73 million.

Other key findings include:

  • There were 18 million adult patients seen in the 24 months up to the end of March 2024
  • There were 6.7 million child patients seen in the 12 months up to the end of March 2024
  • Courses of treatment for adults increased by 2.2 per cent to 23 million, while those for children rose by 9.0 per cent to 11.2 million.
  • Among child treatment courses, more than 56 per cent included fluoride varnish.

The total number of units of dental activity awarded to dental activity claims was 72.5 million in 2023/24, reflecting a 3.4 per cent increase from the previous year but a 9.1 per cent decrease from the 79.7 million UDAs in 2019/20.

Total revenue from patient charges amounted to £774 million in 2023/24, a 2.7 per cent increase from £754 million the previous year.

In February 2024, the previous government introduced the NHS dental recovery plan, backed by £200 million in funding. The plan was designed to provide over 1.5 million additional NHS dental treatments or up to 2.5 million NHS dental appointments within the next 12 months.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less